Actos Lawyer Examine Bladder Cancer Study
Actos Lawyers are closely examining the recent FDA warning comcerning the link between Actos and Bladder cancer. This June, the FDA issued an Actos Warning to Patients who have taken the drug Actos ( Pioglitazone) for more than a year due a potential increased risk of Actos bladder cancer based on a newly released study. Actos may increase the risk of bladder cancer by as much as 40% according to some sources.
Actos Lawyers are questioning why both Germany and France have officially banned use of the drug becasue of its dangers yet remaisn available in the US and are talking to patients who have Bladder Cancer and have taken Actos. These Actos Lawyers hope to seek compensation for those hurt by Actos.
The FDA Actos Warning said diabetes patients taking Actos should tell their doctor if they have any of the above symptoms relating to Actos bladder cancer. Patients should talk to their doctors before making any changes to their medicine use and talk to their doctors about any concerns they have with using Actos.
You may be entitled to Compensation
If you or a loved one has been injured as a result of Actos or want to learn more about the Actos Cancer warning , contact us now to speak to a qualified Actos Lawyer about possible compensation and information about Actos baldder cancer. Call us now at 877-222-7069 or use the contact form for a free case review.
Actos Lawyers are currently reviewing the potential for Actos bladder cancer lawsuits. If it is proven that these drug manufacturers have placed profits ahead of patient safety by failing to adequately warn pateints of this potential risk of bladder cancer, patients diagnosed with bladder cancer may be compensation through an Actos lawsuit. Talk to an Actos Lawyer now to see if you qualify to participate in a Actos Cancer Lawsuit and receive the compensation you deserve.
The FDA annouced on July 6th, that Stryker has announced a voluntary recall of its modular neck...
Hip Replacement Recall Announced
DePuy Orthopaedics, a unit of Johnson & Johnson, announced the...
Innovative Surgical, the manufacture of the Da Vinci Surgery Robot recieved a warning letter from FDA...
ATTORNEY ADVERTISEMENT— The information provided on RecallWarning.com is not a substitute for professional medical or legal advice, diagnosis or treatment. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form does not form an attorney-client relationship with the sponsoring attorney. This website is independent of the FDA or any other medical or Govenmental organization. Information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider.
RecallWarning.com is owned and operated by ProSoftLabs
Let Us Help!